Impact of cystic fibrosis on bone health

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 6, 2010, Pages 616-622

  Haworth, Charles S ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonates; bone mineral density; cystic fibrosis; osteoporosis; vitamin D

Indexed keywords

(1 BUTYLAMINO 3 METHYLBUTYL)(1 PYRROLIDINYL) KETONE; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; CYTOKINE; DECARBOXYPROTHROMBIN; ERGOCALCIFEROL; GROWTH HORMONE; PREDNISONE; TRANSMEMBRANE CONDUCTANCE REGULATOR; VITAMIN K GROUP; ZOLEDRONIC ACID;

BONE DENSITY; BONE METABOLISM; BONE PAIN; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG EFFECT; DRUG EFFICACY; FEVER; FRACTURE; HEADACHE; HUMAN; MUSCULOSKELETAL PAIN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PAIN; PREVALENCE; PROTEIN FUNCTION; REVIEW; RIGOR; SYSTEMATIC REVIEW; VERTEBRA FRACTURE; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

BONE DENSITY; CALCIUM; CHOLECALCIFEROL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIPHOSPHONATES; HUMANS; OSTEOPOROSIS; VITAMIN K;

EID: 77958150311     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833e2e94     Document Type: Review

References (39)

1. Buntain HM, Greer RM, Schluter PJ, et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004; 59:149-155.
2. Sermet-Gaudelus I, Souberbielle JC, Ruiz JC, et al. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med 2007; 175:951-957. (Pubitemid 46684706)
3. Paccou J, Zeboulon N, Combescure C, et al. The prevalence of osteoporosis, osteopenia, and fractures: a systematic literature review with meta-analysis. Calcif Tissue Int 2010; 86:1-7.
4. Haworth CS, Selby PL, Webb AK, et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999; 54:961-967. (Pubitemid 29495388)
5. Aris RM, Merkel PA, Bachrach LK, et al. Consensus statement: guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005; 90: 1888-1896. (Pubitemid 40464064)
6. Buntain HM, Schluter PJ, Bell SC, et al. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 2006; 61:146-154.
7. Haworth CS, Selby PL, Horrrocks AW, et al. A prospective study of change in bone mineral density over one year in adults with cystic fibrosis. Thorax 2002; 57:719-723. (Pubitemid 34864530)
8. Bhudhikanok GS, Wang M-C, Marcus R, et al. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 1998; 133:18-27. (Pubitemid 28323900)
9. Elkin SL, Fairney A, Burnett S, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001; 12:366-372. (Pubitemid 32606460)
10. Conway SP, Morton AM, Oldroyd B, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000; 55:798-804. (Pubitemid 30660911)
11. Haworth CS, Webb AK, Egan JJ, et al. Bone histomorphometry in adult patients with cystic fibrosis. Chest 2000; 118:434-439. (Pubitemid 30637812)
12. Elkin SL, Vedi S, Bord S, et al. Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 2002; 166:1470-1474. (Pubitemid 35387297)
13. Dif F, Marty C, Baudoin C, et al. Severe osteopenia in CFTR-null mice. Bone 2004; 35:595-603. (Pubitemid 39144418)
14. Haston CK, Li W, Li A, et al. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am J Respir Crit Care Med 2008; 177:309-315. (Pubitemid 351198374)
15. Pashuck TD, Franz SE, Altman MK, et al. Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pediatr Res 2009; 65:311-316.
16. Bronckers A, Kalogeraki L, Jorna HJN, et al. The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells. Bone 2010; 46:1188-1196.
17. Shead EF, Haworth CS, Condliffe AM, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax 2007; 62:650-651. (Pubitemid 47056896)
18. Le Heron L, Guillaume C, Velard F, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. J Cyst Fibros 2010; 9:69-72.
19. Shead EF, Haworth CS, Gunn E, et al. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med 2006; 174:306-311. (Pubitemid 44156609)
20. Shead EF, Haworth CS, Barker H, et al. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros 2010; 9:93-98.
21. Aris RM, Stephens AR, Ontjes DA, et al. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 2000; 162:1674-1678.
22. Report of the UK Cystic Fibrosis Trust Bone Mineralisation Working Group. Bone mineralisation in cystic fibrosis. February 2007. Cystic Fibrosis Trust.
23. Wolfenden LL, Judd SE, Shah R, et al. Vitamin D and bone health in adults with cystic fibrosis. Clin Endocrinol 2008; 69:374-381.
24. Lark RK, Lester GE, Ontjes DA, et al. Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr 2001; 73:602-606. (Pubitemid 32176512)
25. Hall WB, Sparks AA, Aris RM. Vitamin D deficiency in cystic fibrosis. Int J Endocrinol 2010; 2010:218691.
26. Khazai NB, Judd SE, Jeng L, et al. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. J Clin Endocrinol Metab 2009; 94:2037-2043.
27. Trang HM, Cole DEC, Rubin LA, et al. Evidence that vitamin D3 increases serum 25-hydroxy vitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998; 68:854-858.
28. Conway SP, Wolfe SP, Brownlee KG, et al. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 2005; 115:1325-1331. (Pubitemid 43843239)
29. Fewtrell MS, Benden C, Williams JE, et al. Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis. J Cyst Fibros 2008; 7:307-312.
30. Grey V, Atkinson S, Drury D, et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008; 122:1014-1020.
31. Nicolaidou P, Stavrinadis I, Loukou I, et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr 2006; 165:540-545. (Pubitemid 43989412)
32. Drury D, Grey VL, Ferland G, et al. Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J Cyst Fibros 2008; 7:457-459.
33. Hillman LS, Cassidy JT, Popescu MF, et al. Percentage true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatr Pulmonol 2008; 43:772-780.
34. Schulze KJ, O'Brien KO, Germain-Lee EL, et al. Endogenous fecal losses of calcium compromise calcium balance in pancreatic insufficient girls with cystic fibrosis. J Pediatr 2003; 143:765-771.
35. Papaioannou A, Kennedy CC, Freitag A, et al. Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS Trial). Chest 2008; 134:794-800.
36. Aris RM, Lester GE, Caminiti M, et al. Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med 2004; 169:77-82. (Pubitemid 38233892)
37. Chapman I, Greville H, Ebeling PR, et al. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). Clin Endocrinol 2009; 70:838-846.
38. Haworth CS, Selby PL, Adams JE, et al. Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis. Thorax 2001; 56:314-316. (Pubitemid 32269814)
39. Hardin DS, Adams-Huet B, Brown D, et al. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial. J Clin Endocrinol Metab 2006; 91:4925-4929. (Pubitemid 44917328)